Roivant Sciences

+$1.37 (+19.46%) Today
-$0.31 (-3.69%) As of 10:29 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ROIV and other ETFs, options, and stocks.

About ROIV

Roivant Sciences Ltd. engages in the biopharmaceutical business, which develops drug candidates Vants in subsidiary companies. Its Vant model enables a modular approach to the monetization of therapies through development, commercialization of some products independently, while selectively establishing partnerships for other Vants or divesting of the Vants entirely.

CEO
Matthew Gline
Employees
2
Headquarters
London, Greater London
Founded
2014

ROIV Key Statistics

Market Cap
6.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
509.08K
High Today
$9.39
Low Today
$7.75
Open Price
$9.08
Volume
2.42M
52 Week High
$9.99
52 Week Low
$5.80

ROIV Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure